PRODUCT LITERATURE

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM Preserved Trial

---

Half of patients with chronic heart failure (CHF) have preserved left-ventricular ejection fraction (LVEF), but few treatments have specific ally been assessed in such patients. In previous studies of patients with CHF and low LVEF or vascular disease and preserved LVEF, inhibition of the renin-angiotensin system is beneficial. We investigatedthe effect of addition of an angiotensin-receptor blocker to
current treatments.

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Candesarta
Chronic Heart Failure

Specific Detail Info

Lancet 2003; 362: 777–81

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment